Nigella sativa: A Potential Antiosteoporotic Agent

Figure 1

The two pathways which may lead to osteoporosis are shown, that is, activation of osteclastic bone resorption activity by free radicals and by inflammation. The inhibition of these two pathways by Nigella sativa or Thymoquinone, its active component, may account for the mechanisms involved in prevention of osteoporosis.